Molecular Partners Home About Us DARPin Biology The DARPin Platform Pipeline Investors Partnering Careers Contact Us ABOUT US Our purpose is to transform the lives of people with serious diseases through our custom-built DARPin® therapeutics. We are pioneers: inventors and developers of an entirely new class of therapeutics. As our name indicates, collaboration is in our DNA: within our team, with our partners, and with patients and providers. We build on deep trust, individual diversity, and shared passion to reach our common goal of surmounting the toughest challenges in medicine, including the treatment of cancer and other serious diseases. Our long-term strategy leverages our in-house DARPin® design and development expertise combined with the capabilities of world-class partners to deliver a broad pipeline of innovative therapeutics. Leadership Patrick Amstutz, Ph.D. Chief Executive Officer and Member of the Management Board, Member of the Board of Directors Michael Tobias Stumpp, Ph.D. Chief Operating Officer and Member of the Management Board Andreas Emmenegger Chief Financial Officer and Member of the Management Board Nicolas Leupin, M.D., Ph.D. Chief Medical Officer and Member of the Management Board Ana Maria Mendes Cerdeira, Ph.D. VP, Strategic Planning and Portfolio Strategy Seth Lewis SVP Investor Relations, Communications and Strategy Robert Hendriks VP Finance Julia Hepp, Ph.D. VP Partnering & Alliance Julien Gander, LL.M. General Counsel, VP Legal Alexander Zürcher SVP Development Daniel Steiner, Ph.D. SVP Research Board of directors William M. Burns Chairman of the Board of Directors Patrick Amstutz, Ph.D. Chief Executive Officer and Member of the Board of Directors Agnete Fredriksen, Ph.D. Member of the Board of Directors Dominik Höchli, M.D. Member of the Board of Directors Steven H. Holtzman Member of the Board of Directors Sandip Kapadia Member of the Board of Directors Vito J. Palombella, Ph.D. Member of the Board of Directors Michael Vasconcelles, M.D. Member of the Board of Directors Research & Development Committee: Michael Vasconcelles (Chair), Agnete Fredriksen, Vito Palombella Nomination & Compensation Committee: William Burns (Chair), Steven Holtzman, Michael Vasconcelles Audit & Finance Committee: Sandip Kapadia (Chair), Dominik Höchli, Steven Holtzman COOKIE NOTICE PRIVACY & DISCLAIMER CONTACT US © 2021 Molecular Partners.